Three million child deaths linked to drug resistance

According to a study by two leading experts in Child Health, more than three million children worldwide died in 2022 as a result of resistant infections of antibiotics.

In Africa and Southeast Asia, children were found to be the highest threat.

Antimicrobial resistance – is known as AMR – develops when the germs that cause infection are developed in such a way that antibiotics no longer work.

It has been identified as one of the largest public health hazards in front of the world’s population.

A new study now shows AMR to children, showing that toll.

Using data from many sources including the World Health Organization (WHO) and the World Bank, the authors of the report have calculated that in 2022 there were more than three million child deaths associated with drug-resistant infections.

Experts say that this new study highlights more than ten times the increase in infections related to AMR in children in just three years.

The number of Kovid epidemic could have been worse.

Antibiotics are used to treat or prevent a huge range of bacterial infections – everything from skin infection to pneumonia.

They are also given as a precaution to stop instead of treatment, an infection – for example if a person is performing an operation or receiving chemotherapy treatment for cancer.

Antibiotics have no effect on viral infections, however – diseases like common cold, flu or covid.

But some bacteria have now developed resistance to some drugs, due to their excessive use and improper use, while the production of new antibiotics – a long and expensive process – has slowed down.

The main author of the report, Dr. Yanhong Jessica Hu, a doctor at the Murdoch Children’s Research Institute in Australia and Herb Harvel, Professor at Clinton Health Access Initiative, indicate a significant increase in the use of antibiotics that are held back to only the most serious infections.

The use of “watch antibiotics” between 2019 and 2021, high -risk drugs of resistance, 160% in Southeast Asia and 126% in Africa.

In the same period, “reserved antibiotics” – severe, multidrig – final -reliable treatment for anti -protest infections – 45% in Southeast Asia and 125% in Africa.

Authors have warned that if bacteria develop resistance to these antibiotics, some, if any, will be the options for the treatment of multidrig-resistant infections.

Professor Harvell is offering conclusions in the Congress of European Society of Clinical Microbiology and infectious diseases in Vienna later this month.

He said, “AMR is a global problem. It affects everyone. We actually did this work to focus on the way AMR affects children,” he said.

“We estimate three million deaths worldwide associated with antimicrobial resistance.”

WHO describes AMR as one of the most serious global health hazards We cope, but speaking to Vienna, Prof. Harvel warns that there are no easy answers.

“This is a multidimensional problem that extends into all aspects of therapy and in fact,” he said.

“Antibiotics are omnipresent around us, they are finished in our food and environment and therefore it is not easy to come with the same solution.”

The best way to avoid a resistant infection is to completely avoid infection, which means high level vaccination, water hygiene and hygiene, he says.

“There is more antibiotics going to use because there are more people who need them, but we need to ensure that they are used properly and the right drugs are used.”

Dr., a senior lecturer of microbiology at King’s College London. Lindsay Edwards stated that the new study “marks a significant and dangerous growth compared to previous data”.

“These findings should act as a wake-up call for global health leaders. Without decisive action, AMR can reduce the progress of decades in child health, especially in the world’s weakest areas.”